<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01096264</url>
  </required_header>
  <id_info>
    <org_study_id>2009-03</org_study_id>
    <nct_id>NCT01096264</nct_id>
  </id_info>
  <brief_title>Non-Invasive Quantitative Imaging of Human Local Arterial Wall Elasticity Using Supersonic Shear Imaging</brief_title>
  <acronym>ULTRAFASTECHO</acronym>
  <official_title>Establishment of Local Arterial Stiffness Normal Values (Carotid and Femoral) on Healthy Volunteers Using Supersonic Shear Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>French Cardiology Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research Agency, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SOCIETE FRANCAISE DE MEDECINE VASCULAIRE</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>French Cardiology Society</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Arterial stiffness is associated with increased risk of cardiovascular events and death.

      Most of existing technique need dedicated device for arterial stiffness evaluation and
      indirect calculation of intra arterial pressure. Supersonic Shear Imaging (SSI) is a novel
      non-invasive technique based on remote palpation of biological tissues that can image with
      very high temporal resolution (up to 10,000 images/s) and quantify the local viscoelastic
      properties of tissues. The investigators goal was to apply this SSI technique for arterial
      stiffness evaluation and local pulse wave velocity (PWV) calculation.

      As a first step, the primary goal of this study is to establish normal values of local pulse
      wave velocity and arterial stiffness (carotid and femoral) by SSI on hundred healthy
      volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Provide a more extensive description, if desired. Avoid duplication of information to be
      recorded elsewhere, such as eligibility criteria or outcome measures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Normal Values by SSI</measure>
    <time_frame>day one</time_frame>
    <description>Normal Values by SSI of local PWV and arterial wall stiffness(carotid and femoral).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>repeatability of the &quot;primary outcome measure&quot;</measure>
    <time_frame>Day one</time_frame>
    <description>Evaluation of the repeatability of the &quot;primary outcome measure&quot; on 100 healthy volunteers and 30 patients with Vascular Ehlers Danlos Syndrome (vEDS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison between 2 populations of values by SSI</measure>
    <time_frame>Day one</time_frame>
    <description>Comparison between healthy volunteers and vEDS patients for PWV and arterial stiffness evaluated by SSI.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of values between SSI and standard gold</measure>
    <time_frame>Day one</time_frame>
    <description>Concordance evaluation between PWV calculated by SSI and Aortic Pulse wave velocity calculated by ShygmoCor®</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">145</enrollment>
  <condition>Healthy Volunteers</condition>
  <condition>Vascular Ehlers Danlos Syndrome</condition>
  <arm_group>
    <arm_group_label>Healthy volunteer</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Healthy volunteer undergoing two imagery evaluation :
SSI technique for local PWV and arterial stiffness evaluation
SphygmoCor® for aortic PWV.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vEDS patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>vEDS patients undergoing two imagery evaluations:
SSI technique for local PWV and arterial stiffness evaluation
SphygmoCor® for aortic PWV.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SSI and SphygmoCor® evaluations</intervention_name>
    <description>SSI evaluation need Aixplorer vascular ultrasound machine (available in our department) with 8 MHz linear array probe applied on the carotid and femoral artery.
SphygmoCor® evaluation used pressure captors on carotid and femoral sites to record the intra-arterial pressure wave time delay after QRS wave. After distance calculation between the two sites, Aortic PWV can be derived.</description>
    <arm_group_label>Healthy volunteer</arm_group_label>
    <arm_group_label>vEDS patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria for Healthy Volunteers

          -  Healthy volunteers between 18 and 70 years old of two sexes.

          -  Caucasian origin

          -  No tobacco or stopped for more than 5 years

          -  BMI between 18 and 30 kg/m2.

          -  Blood pressure after 5 minutes of rest &lt; 140 and 90 mmHg.

          -  Biological test (haematological biochemistry test in blood , urine test and toxicology
             tests are all normal) ECG, Blood pressure and Heart rhythm normal.

          -  All volunteers received information on the research and signed the consent form.

          -  Health system protection required

        Inclusion criteria for patient :

          -  Age between, 18 et 70 years old for the two sexes

          -  Presence of two major criteria of Villefranche classification (Am J Med Genet 1998
             ;77:31-7) and/or heterozygote pathogen mutation of COL3A1 gene.

          -  At least 4cm long normal arterial segment (carotid or femoral) analyzed by mode B
             echograph.

          -  All patient received information on the research and signed the consent form.

          -  Health system protection required

        General Exclusion Criteria :

          -  Pregnancy

          -  Echograph gel allergy

          -  Local Artery disease (dissection or thrombosis)

          -  Arrhythmia

          -  No health insurance coverage

          -  Incapacity or refused to sign the consent form

        Exclusion criteria for Healthy volunteers

          -  Acute or Chronic Systemic disease (atherosclerosis)

          -  Alcohol abuse or drug abuse (cocaine,cannabis,etc..)

          -  Active or past tobacco

          -  Hypercholesterolemia (LDLc &gt;1.09 g/l)

          -  Exclusion period according to the national record for volunteer of clinical trial.

        Exclusion criteria for Patients

          -  No intact (carotid or femoral) segment for SSI analysis

          -  AT2 inhibitors or Beta blockers treatment will be notified but are not considered as
             exclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel Messas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Européen Georges-Pompidou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anne Blanchard, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Européen Georges-Pompidou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joseph Emmerich, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Européen Georges-Pompidou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xavier Jeunemaitre, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Européen Georges-Pompidou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Franck, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Européen Georges-Pompidou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Olivier Steinchen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Européen Georges-Pompidou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michel Azizi, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Européen Georges-Pompidou</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CIC - Hôpital Européen Georges Pompidou</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2010</study_first_submitted>
  <study_first_submitted_qc>March 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2010</study_first_posted>
  <last_update_submitted>March 6, 2015</last_update_submitted>
  <last_update_submitted_qc>March 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 9, 2015</last_update_posted>
  <responsible_party>
    <name_title>Dr Emmanuel Messas</name_title>
    <organization>Hôpital Européen Georges Pompidou</organization>
  </responsible_party>
  <keyword>Arterial stiffness</keyword>
  <keyword>Pulse wave velocity</keyword>
  <keyword>Ultrafastecho</keyword>
  <keyword>Supersonic shear imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ehlers-Danlos Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

